Supplementary Figure S2 from Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy

Authors

Lini Huang
Shiyong Gong
Xuan Wu
Danqing Wu (ORCID: https://orcid.org/0009-0002-2711-4721)
Chengbin Wu (ORCID: https://orcid.org/0000-0001-6160-5327)
Rui Zhang
Naren Gaowa

Publication Details

Published: 2025-10-01
DOI: https://doi.org/10.1158/1535-7163.30255388
Primary Topic: Monoclonal and Polyclonal Antibodies Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Supplementary Figure S2 from Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy

Lini Huang, Shiyong Gong, Xuan Wu, Danqing Wu et al.

Oct 1, 2025

Monoclonal and Polyclonal Antibodies Research

article

Supplementary Figure S2 from Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy

Lini Huang, Shiyong Gong, Xuan Wu, Danqing Wu, Chengbin Wu, Rui Zhang, Naren Gaowa

October 1, 2025article en

Abstract

No abstract available for this paper.

Openalex Percentile: Top 59%

Monoclonal and Polyclonal Antibodies Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Supplementary Figure S2 from Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy — Lini Huang, Shiyong Gong, et al. · (2025) | TGRS Research Map | TGRS